Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09EWK
|
|||
| Former ID |
DIB007311
|
|||
| Drug Name |
PRO-053
|
|||
| Synonyms |
Exon-53 skipping antisense oligonucleotide (Duchenne muscular dystrophy), Prosensa
Click to Show/Hide
|
|||
| Indication | Duchenne dystrophy [ICD-11: 8C70; ICD-10: G71.0] | Phase 1/2 | [1] | |
| Company |
Prosensa Therapeutics BV
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01957059) A Phase I/II Study of PRO053 in Subjects With Duchenne Muscular Dystrophy (DMD). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.